12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 298 participants.
Also called NCT02647320
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 298 participants
- Sponsor
- Registry
-
NCT02647320
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02647320. Randomized; quadruple masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2017-01-31 (actual). Results posted on 2018-05-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Sitagliptin 100 mg
- Intervention (Drug)
- DS-8500a 25mg
- Intervention (Drug)
- Placebo Tablet
- Intervention (Drug)
- Placebo Capsule
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02647320- Content hash
bd2ea30bb96780ab00f6b0b46ebe8135ee49c93ef7f7269dd2701526025c8e59